SynthesisCancer chemotherapy and pharmacology2023

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.

Chenxi Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.